Posttreatment chronic Lyme disease - What it is not

Journal of Infectious Diseases

Volumn 192, Issue 6, 2005, Pages 948-949

  Radolf, Justin ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE;

ANIMAL MODEL; AUTOIMMUNITY; BACTERIAL GENOME; BORRELIA BURGDORFERI; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HLA TYPING; HUMAN; LARGE JOINT SYNOVITIS; LYME DISEASE; PERSISTENT INFECTION; POSTTREATMENT CHRONIC LYME DISEASE; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYNOVITIS; TREATMENT FAILURE;

HAPLOTYPES; HLA ANTIGENS; HUMANS; LYME DISEASE;

EID: 24644485223     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432736     Document Type: Editorial

References (20)

1. Steere AC, Malawista SE, Syndman DR, et al. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20:7-17.
2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982; 216: 1317-9.
3. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983; 308:740-2.
4. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308:733-40.
5. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis 2003; 3:489-500.
6. Casjens S, Palmer N, van Vugt R, et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000; 35:490-516.
7. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997; 390:580-6.
8. Rosa PA, Tilly K, Stewart PE. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol 2005; 3:129-43.
9. Barthold SW, Beck DS, Hansen GM, Terwilliger AA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990; 162:133-8.
10. Woolen RM, Weis JJ. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol 2001; 4:274-9.
11. Salazar JC, Pope CD, Sellati TJ, et al. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol 2003; 171:2660-70.
12. Pal U, Fikrig E. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes and Infection 2003; 5:659-66.
13. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184:1070-2.
14. Benhnia MR, Wroblewski D, Akhtar MN, et al. Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease. J Immunol 2005; 174:1539-48.
15. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 2002; 14:383-7.
16. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990; 323:219-23.
17. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281:703-6.
18. Edlow JA. Bull's eye: unraveling the mystery of Lyme disease. New Haven, CT: Yale University Press, 2003.
19. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85-92.
20. Klempner MS, Wormser GH, Wade K, et al. A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis 2005; 192:1010-3 (in this issue).